4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-048199
Chief Financial Officer gave up 285 shares (to pay taxes)
- Chief Financial Officer acquired 1,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Balthaser Kevin Chief Financial Officer | 2023-09-01 | Option exercise | +1,000 | 6,256 | D | ||
| Balthaser Kevin Chief Financial Officer | 2023-09-01 | Shares withheld for taxes | −285 | $7.90 | $2,252 | 5,971 | D |
| Derivatives | |||||||
| Balthaser Kevin Chief Financial Officer | 2023-09-01 | Option exercise · Restricted Stock Units | −1,000 | 1,000 | D | ||
Loading xslF345X05/doc4.xml…